Stay updated on SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.
Latest updates to the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.1%
- Check18 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check54 days agoChange DetectedThe website has been updated to version v2.10.0, adding two more interventions/treatments and indicating that the study now has one location.SummaryDifference0.5%
- Check61 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check75 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.1%
- Check80 days agoChange DetectedThe value of 'Follicular Lymphoma Lymphosarcoma' has been updated to 'Lymphosarcoma Follicular Lymphoma' in the recent revision v2.9.5. This change represents an alteration in the order of the terms within the value.SummaryDifference0.3%
Stay in the know with updates to SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.